Zhejiang Gongdong Medical Technology Co.,Ltd. (605369.SS)
CNY 23.53
(-0.21%)
CNY 23.53
(-0.21%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 200.09 Million CNY | -49.84% |
| 2022 | 411.93 Million CNY | 10.37% |
| 2021 | 382.56 Million CNY | 34.02% |
| 2020 | 281.51 Million CNY | 89.18% |
| 2019 | 149.02 Million CNY | 33.73% |
| 2018 | 111.93 Million CNY | 68.3% |
| 2017 | 69.25 Million CNY | -21.39% |
| 2016 | 83.27 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 53.93 Million CNY | 89.43% |
| 2024 Q3 | 49.75 Million CNY | -36.0% |
| 2024 Q2 | 68.93 Million CNY | 18.99% |
| 2023 Q3 | 17 Million CNY | -50.15% |
| 2023 FY | - CNY | -49.84% |
| 2023 Q4 | 38.99 Million CNY | 129.38% |
| 2023 Q2 | 34.1 Million CNY | -9.19% |
| 2023 Q1 | 37.55 Million CNY | -17.28% |
| 2022 Q4 | 45.39 Million CNY | -43.67% |
| 2022 Q3 | 80.58 Million CNY | -43.09% |
| 2022 Q2 | 141.6 Million CNY | 25.24% |
| 2022 Q1 | 113.06 Million CNY | 27.57% |
| 2022 FY | - CNY | 10.37% |
| 2021 Q4 | 88.62 Million CNY | -0.13% |
| 2021 FY | - CNY | 34.02% |
| 2021 Q1 | 75.82 Million CNY | 3.06% |
| 2021 Q2 | 107.25 Million CNY | 41.46% |
| 2021 Q3 | 88.74 Million CNY | -17.26% |
| 2020 Q4 | 73.57 Million CNY | -10.6% |
| 2020 Q2 | 85.03 Million CNY | 234.75% |
| 2020 Q1 | 25.4 Million CNY | -32.43% |
| 2020 FY | - CNY | 89.18% |
| 2020 Q3 | 82.29 Million CNY | -3.22% |
| 2019 FY | - CNY | 33.73% |
| 2019 Q4 | 37.59 Million CNY | -3.79% |
| 2019 Q3 | 39.07 Million CNY | 10.56% |
| 2019 Q2 | 35.33 Million CNY | 10.14% |
| 2019 Q1 | 32.08 Million CNY | 0.0% |
| 2018 FY | - CNY | 68.3% |
| 2017 FY | - CNY | -21.39% |
| 2016 FY | - CNY | 0.0% |